We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.06 | -4.74873213462 | 43.38 | 44.015 | 40.73 | 1057494 | 41.79695191 | CS |
| 4 | 0.97 | 2.40396530359 | 40.35 | 44.68 | 39.36 | 1279368 | 41.77714324 | CS |
| 12 | -15.74 | -27.5849982475 | 57.06 | 59.72 | 39.36 | 1582976 | 45.48264481 | CS |
| 26 | -1.6 | -3.72786579683 | 42.92 | 62.4 | 39.36 | 1339757 | 47.3846969 | CS |
| 52 | 11.83 | 40.1152933198 | 29.49 | 62.4 | 28.43 | 1406047 | 42.36429413 | CS |
| 156 | 19.91 | 92.993928071 | 21.41 | 62.4 | 14.08 | 1271971 | 30.93393911 | CS |
| 260 | 11.97 | 40.7836456559 | 29.35 | 62.4 | 14.08 | 953658 | 31.35607797 | CS |
Monksdream
4 months ago
axelvento
10 months ago
axelvento
10 months ago
Monksdream
10 months ago
Monksdream
12 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
